Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 37 entries
Sorted by: Best Match Show Resources per page
Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Hellinen L, Koskela A, Vattulainen E, Liukkonen M, Wegler C, Treyer A, Handin N, Svensson R, Myöhänen T, Poso A, Kaarniranta K, Artursson P, Urtti A.
PMID: 34891119
Biomed Pharmacother. 2021 Dec 07;146:112501. doi: 10.1016/j.biopha.2021.112501. Epub 2021 Dec 07.

Dry age-related macular degeneration (AMD) is a currently untreatable vision threatening disease. Impaired proteasomal clearance and autophagy in the retinal pigment epithelium (RPE) and subsequent photoreceptor damage are connected with dry AMD, but detailed pathophysiology is still unclear. In...

Cite
Hellinen L, Koskela A, Vattulainen E, et al. Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomed Pharmacother. 2021;146:112501doi: 10.1016/j.biopha.2021.112501.
Hellinen, L., Koskela, A., Vattulainen, E., Liukkonen, M., Wegler, C., Treyer, A., Handin, N., Svensson, R., Myöhänen, T., Poso, A., Kaarniranta, K., Artursson, P., & Urtti, A. (2021). Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 146112501. https://doi.org/10.1016/j.biopha.2021.112501
Hellinen, Laura, et al. "Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 146 (2021): 112501. doi: https://doi.org/10.1016/j.biopha.2021.112501
Hellinen L, Koskela A, Vattulainen E, Liukkonen M, Wegler C, Treyer A, Handin N, Svensson R, Myöhänen T, Poso A, Kaarniranta K, Artursson P, Urtti A. Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomed Pharmacother. 2021 Dec 07;146:112501. doi: 10.1016/j.biopha.2021.112501. Epub 2021 Dec 07. PMID: 34891119.
Copy Download .nbib Format: NLM
2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors.

ACS medicinal chemistry letters

Pätsi HT, Kilpeläinen TP, Auno S, Dillemuth PMJ, Arja K, Lahtela-Kakkonen MK, Myöhänen TT, Wallén EAA.
PMID: 34671446
ACS Med Chem Lett. 2021 Sep 17;12(10):1578-1584. doi: 10.1021/acsmedchemlett.1c00399. eCollection 2021 Oct 14.

Different five-membered nitrogen-containing heteroaromatics in the position of the typical electrophilic group in prolyl oligopeptidase (PREP) inhibitors were investigated and compared to tetrazole. The 2-imidazoles were highly potent inhibitors of the proteolytic activity. The binding mode for the basic...

Cite
Pätsi HT, Kilpeläinen TP, Auno S, et al. 2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors. ACS Med Chem Lett. 2021;12(10):1578-1584doi: 10.1021/acsmedchemlett.1c00399.
Pätsi, H. T., Kilpeläinen, T. P., Auno, S., Dillemuth, P. M. J., Arja, K., Lahtela-Kakkonen, M. K., Myöhänen, T. T., & Wallén, E. A. A. (2021). 2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors. ACS medicinal chemistry letters, 12(10), 1578-1584. https://doi.org/10.1021/acsmedchemlett.1c00399
Pätsi, Henri T, et al. "2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors." ACS medicinal chemistry letters vol. 12,10 (2021): 1578-1584. doi: https://doi.org/10.1021/acsmedchemlett.1c00399
Pätsi HT, Kilpeläinen TP, Auno S, Dillemuth PMJ, Arja K, Lahtela-Kakkonen MK, Myöhänen TT, Wallén EAA. 2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors. ACS Med Chem Lett. 2021 Sep 17;12(10):1578-1584. doi: 10.1021/acsmedchemlett.1c00399. eCollection 2021 Oct 14. PMID: 34671446; PMCID: PMC8521653.
Copy Download .nbib Format: NLM
Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Hellinen L, Koskela A, Vattulainen E, Liukkonen M, Wegler C, Treyer A, Handin N, Svensson R, Myöhänen T, Poso A, Kaarniranta K, Artursson P, Urtti A.
PMID: 34891119
Biomed Pharmacother. 2021 Dec 07;146:112501. doi: 10.1016/j.biopha.2021.112501. Epub 2021 Dec 07.

Dry age-related macular degeneration (AMD) is a currently untreatable vision threatening disease. Impaired proteasomal clearance and autophagy in the retinal pigment epithelium (RPE) and subsequent photoreceptor damage are connected with dry AMD, but detailed pathophysiology is still unclear. In...

Cite
Hellinen L, Koskela A, Vattulainen E, et al. Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomed Pharmacother. 2021;146:112501doi: 10.1016/j.biopha.2021.112501.
Hellinen, L., Koskela, A., Vattulainen, E., Liukkonen, M., Wegler, C., Treyer, A., Handin, N., Svensson, R., Myöhänen, T., Poso, A., Kaarniranta, K., Artursson, P., & Urtti, A. (2021). Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 146112501. https://doi.org/10.1016/j.biopha.2021.112501
Hellinen, Laura, et al. "Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 146 (2021): 112501. doi: https://doi.org/10.1016/j.biopha.2021.112501
Hellinen L, Koskela A, Vattulainen E, Liukkonen M, Wegler C, Treyer A, Handin N, Svensson R, Myöhänen T, Poso A, Kaarniranta K, Artursson P, Urtti A. Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomed Pharmacother. 2021 Dec 07;146:112501. doi: 10.1016/j.biopha.2021.112501. Epub 2021 Dec 07. PMID: 34891119.
Copy Download .nbib Format: NLM
Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy.

Biochemical pharmacology

Cui H, Norrbacka S, Myöhänen TT.
PMID: 34968496
Biochem Pharmacol. 2021 Dec 28;197:114899. doi: 10.1016/j.bcp.2021.114899. Epub 2021 Dec 28.

The accumulation of aggregated α-synuclein (α-syn) has been identified as the primary component of Lewy bodies that are the pathological hallmarks of Parkinson's disease (PD). Several preclinical studies have shown α-syn aggregation, and particularly the intermediates formed during the...

Cite
Cui H, Norrbacka S, Myöhänen TT. Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy. Biochem Pharmacol. 2021;197:114899doi: 10.1016/j.bcp.2021.114899.
Cui, H., Norrbacka, S., & Myöhänen, T. T. (2021). Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy. Biochemical pharmacology, 197114899. https://doi.org/10.1016/j.bcp.2021.114899
Cui, H, et al. "Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy." Biochemical pharmacology vol. 197 (2021): 114899. doi: https://doi.org/10.1016/j.bcp.2021.114899
Cui H, Norrbacka S, Myöhänen TT. Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy. Biochem Pharmacol. 2021 Dec 28;197:114899. doi: 10.1016/j.bcp.2021.114899. Epub 2021 Dec 28. PMID: 34968496.
Copy Download .nbib Format: NLM
The Way of Distance Teaching Is Related to Adolescent Students' Health and Loneliness during the School Closure in Finland.

International journal of environmental research and public health

Rimpelä A, Lindfors P, Kinnunen JM, Myöhänen A, Hotulainen R, Koivuhovi S, Vainikainen MP.
PMID: 34886104
Int J Environ Res Public Health. 2021 Nov 25;18(23). doi: 10.3390/ijerph182312377.

The COVID-19 pandemic enforced countries to close schools and rapidly transfer to distance teaching without preparation. Little is known about how different distance teaching practices influenced students' wellbeing. We studied this during the period of school closures in Finland....

Cite
Rimpelä A, Lindfors P, Kinnunen JM, et al. The Way of Distance Teaching Is Related to Adolescent Students' Health and Loneliness during the School Closure in Finland. Int J Environ Res Public Health. 2021;18(23)doi: 10.3390/ijerph182312377.
Rimpelä, A., Lindfors, P., Kinnunen, J. M., Myöhänen, A., Hotulainen, R., Koivuhovi, S., & Vainikainen, M. P. (2021). The Way of Distance Teaching Is Related to Adolescent Students' Health and Loneliness during the School Closure in Finland. International journal of environmental research and public health, 18(23), . https://doi.org/10.3390/ijerph182312377
Rimpelä, Arja, et al. "The Way of Distance Teaching Is Related to Adolescent Students' Health and Loneliness during the School Closure in Finland." International journal of environmental research and public health vol. 18,23 (2021). doi: https://doi.org/10.3390/ijerph182312377
Rimpelä A, Lindfors P, Kinnunen JM, Myöhänen A, Hotulainen R, Koivuhovi S, Vainikainen MP. The Way of Distance Teaching Is Related to Adolescent Students' Health and Loneliness during the School Closure in Finland. Int J Environ Res Public Health. 2021 Nov 25;18(23). doi: 10.3390/ijerph182312377. PMID: 34886104.
Copy Download .nbib Format: NLM
Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy.

Biochemical pharmacology

Cui H, Norrbacka S, Myöhänen TT.
PMID: 34968496
Biochem Pharmacol. 2021 Dec 28;197:114899. doi: 10.1016/j.bcp.2021.114899. Epub 2021 Dec 28.

The accumulation of aggregated α-synuclein (α-syn) has been identified as the primary component of Lewy bodies that are the pathological hallmarks of Parkinson's disease (PD). Several preclinical studies have shown α-syn aggregation, and particularly the intermediates formed during the...

Cite
Cui H, Norrbacka S, Myöhänen TT. Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy. Biochem Pharmacol. 2021;197:114899doi: 10.1016/j.bcp.2021.114899.
Cui, H., Norrbacka, S., & Myöhänen, T. T. (2021). Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy. Biochemical pharmacology, 197114899. https://doi.org/10.1016/j.bcp.2021.114899
Cui, H, et al. "Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy." Biochemical pharmacology vol. 197 (2021): 114899. doi: https://doi.org/10.1016/j.bcp.2021.114899
Cui H, Norrbacka S, Myöhänen TT. Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy. Biochem Pharmacol. 2021 Dec 28;197:114899. doi: 10.1016/j.bcp.2021.114899. Epub 2021 Dec 28. PMID: 34968496.
Copy Download .nbib Format: NLM
Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Hellinen L, Koskela A, Vattulainen E, Liukkonen M, Wegler C, Treyer A, Handin N, Svensson R, Myöhänen T, Poso A, Kaarniranta K, Artursson P, Urtti A.
PMID: 34891119
Biomed Pharmacother. 2021 Dec 07;146:112501. doi: 10.1016/j.biopha.2021.112501. Epub 2021 Dec 07.

Dry age-related macular degeneration (AMD) is a currently untreatable vision threatening disease. Impaired proteasomal clearance and autophagy in the retinal pigment epithelium (RPE) and subsequent photoreceptor damage are connected with dry AMD, but detailed pathophysiology is still unclear. In...

Cite
Hellinen L, Koskela A, Vattulainen E, et al. Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomed Pharmacother. 2021;146:112501doi: 10.1016/j.biopha.2021.112501.
Hellinen, L., Koskela, A., Vattulainen, E., Liukkonen, M., Wegler, C., Treyer, A., Handin, N., Svensson, R., Myöhänen, T., Poso, A., Kaarniranta, K., Artursson, P., & Urtti, A. (2021). Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 146112501. https://doi.org/10.1016/j.biopha.2021.112501
Hellinen, Laura, et al. "Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 146 (2021): 112501. doi: https://doi.org/10.1016/j.biopha.2021.112501
Hellinen L, Koskela A, Vattulainen E, Liukkonen M, Wegler C, Treyer A, Handin N, Svensson R, Myöhänen T, Poso A, Kaarniranta K, Artursson P, Urtti A. Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomed Pharmacother. 2021 Dec 07;146:112501. doi: 10.1016/j.biopha.2021.112501. Epub 2021 Dec 07. PMID: 34891119.
Copy Download .nbib Format: NLM
Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy.

Biochemical pharmacology

Cui H, Norrbacka S, Myöhänen TT.
PMID: 34968496
Biochem Pharmacol. 2021 Dec 27;114899. doi: 10.1016/j.bcp.2021.114899. Epub 2021 Dec 27.

The accumulation of aggregated α-synuclein (α-syn) has been identified as the primary component of Lewy bodies that are the pathological hallmarks of Parkinson's disease (PD). Several preclinical studies have shown α-syn aggregation, and particularly the intermediates formed during the...

Cite
Cui H, Norrbacka S, Myöhänen TT. Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy. Biochem Pharmacol. 2021;114899doi: 10.1016/j.bcp.2021.114899.
Cui, H., Norrbacka, S., & Myöhänen, T. T. (2021). Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy. Biochemical pharmacology, 114899. https://doi.org/10.1016/j.bcp.2021.114899
Cui, H, et al. "Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy." Biochemical pharmacology vol. (2021): 114899. doi: https://doi.org/10.1016/j.bcp.2021.114899
Cui H, Norrbacka S, Myöhänen TT. Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy. Biochem Pharmacol. 2021 Dec 27;114899. doi: 10.1016/j.bcp.2021.114899. Epub 2021 Dec 27. PMID: 34968496.
Copy Download .nbib Format: NLM
Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Hellinen L, Koskela A, Vattulainen E, Liukkonen M, Wegler C, Treyer A, Handin N, Svensson R, Myöhänen T, Poso A, Kaarniranta K, Artursson P, Urtti A.
PMID: 34891119
Biomed Pharmacother. 2021 Dec 07;146:112501. doi: 10.1016/j.biopha.2021.112501. Epub 2021 Dec 07.

Dry age-related macular degeneration (AMD) is a currently untreatable vision threatening disease. Impaired proteasomal clearance and autophagy in the retinal pigment epithelium (RPE) and subsequent photoreceptor damage are connected with dry AMD, but detailed pathophysiology is still unclear. In...

Cite
Hellinen L, Koskela A, Vattulainen E, et al. Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomed Pharmacother. 2021;146:112501doi: 10.1016/j.biopha.2021.112501.
Hellinen, L., Koskela, A., Vattulainen, E., Liukkonen, M., Wegler, C., Treyer, A., Handin, N., Svensson, R., Myöhänen, T., Poso, A., Kaarniranta, K., Artursson, P., & Urtti, A. (2021). Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 146112501. https://doi.org/10.1016/j.biopha.2021.112501
Hellinen, Laura, et al. "Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 146 (2021): 112501. doi: https://doi.org/10.1016/j.biopha.2021.112501
Hellinen L, Koskela A, Vattulainen E, Liukkonen M, Wegler C, Treyer A, Handin N, Svensson R, Myöhänen T, Poso A, Kaarniranta K, Artursson P, Urtti A. Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomed Pharmacother. 2021 Dec 07;146:112501. doi: 10.1016/j.biopha.2021.112501. Epub 2021 Dec 07. PMID: 34891119.
Copy Download .nbib Format: NLM
Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Hellinen L, Koskela A, Vattulainen E, Liukkonen M, Wegler C, Treyer A, Handin N, Svensson R, Myöhänen T, Poso A, Kaarniranta K, Artursson P, Urtti A.
PMID: 34891119
Biomed Pharmacother. 2021 Dec 07;146:112501. doi: 10.1016/j.biopha.2021.112501. Epub 2021 Dec 07.

Dry age-related macular degeneration (AMD) is a currently untreatable vision threatening disease. Impaired proteasomal clearance and autophagy in the retinal pigment epithelium (RPE) and subsequent photoreceptor damage are connected with dry AMD, but detailed pathophysiology is still unclear. In...

Cite
Hellinen L, Koskela A, Vattulainen E, et al. Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomed Pharmacother. 2021;146:112501doi: 10.1016/j.biopha.2021.112501.
Hellinen, L., Koskela, A., Vattulainen, E., Liukkonen, M., Wegler, C., Treyer, A., Handin, N., Svensson, R., Myöhänen, T., Poso, A., Kaarniranta, K., Artursson, P., & Urtti, A. (2021). Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 146112501. https://doi.org/10.1016/j.biopha.2021.112501
Hellinen, Laura, et al. "Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 146 (2021): 112501. doi: https://doi.org/10.1016/j.biopha.2021.112501
Hellinen L, Koskela A, Vattulainen E, Liukkonen M, Wegler C, Treyer A, Handin N, Svensson R, Myöhänen T, Poso A, Kaarniranta K, Artursson P, Urtti A. Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomed Pharmacother. 2021 Dec 07;146:112501. doi: 10.1016/j.biopha.2021.112501. Epub 2021 Dec 07. PMID: 34891119.
Copy Download .nbib Format: NLM
Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Hellinen L, Koskela A, Vattulainen E, Liukkonen M, Wegler C, Treyer A, Handin N, Svensson R, Myöhänen T, Poso A, Kaarniranta K, Artursson P, Urtti A.
PMID: 34891119
Biomed Pharmacother. 2021 Dec 07;146:112501. doi: 10.1016/j.biopha.2021.112501. Epub 2021 Dec 07.

Dry age-related macular degeneration (AMD) is a currently untreatable vision threatening disease. Impaired proteasomal clearance and autophagy in the retinal pigment epithelium (RPE) and subsequent photoreceptor damage are connected with dry AMD, but detailed pathophysiology is still unclear. In...

Cite
Hellinen L, Koskela A, Vattulainen E, et al. Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomed Pharmacother. 2021;146:112501doi: 10.1016/j.biopha.2021.112501.
Hellinen, L., Koskela, A., Vattulainen, E., Liukkonen, M., Wegler, C., Treyer, A., Handin, N., Svensson, R., Myöhänen, T., Poso, A., Kaarniranta, K., Artursson, P., & Urtti, A. (2021). Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 146112501. https://doi.org/10.1016/j.biopha.2021.112501
Hellinen, Laura, et al. "Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 146 (2021): 112501. doi: https://doi.org/10.1016/j.biopha.2021.112501
Hellinen L, Koskela A, Vattulainen E, Liukkonen M, Wegler C, Treyer A, Handin N, Svensson R, Myöhänen T, Poso A, Kaarniranta K, Artursson P, Urtti A. Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration. Biomed Pharmacother. 2021 Dec 07;146:112501. doi: 10.1016/j.biopha.2021.112501. Epub 2021 Dec 07. PMID: 34891119.
Copy Download .nbib Format: NLM
Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy.

Biochemical pharmacology

Cui H, Norrbacka S, Myöhänen TT.
PMID: 34968496
Biochem Pharmacol. 2021 Dec 28;197:114899. doi: 10.1016/j.bcp.2021.114899. Epub 2021 Dec 28.

The accumulation of aggregated α-synuclein (α-syn) has been identified as the primary component of Lewy bodies that are the pathological hallmarks of Parkinson's disease (PD). Several preclinical studies have shown α-syn aggregation, and particularly the intermediates formed during the...

Cite
Cui H, Norrbacka S, Myöhänen TT. Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy. Biochem Pharmacol. 2021;197:114899doi: 10.1016/j.bcp.2021.114899.
Cui, H., Norrbacka, S., & Myöhänen, T. T. (2021). Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy. Biochemical pharmacology, 197114899. https://doi.org/10.1016/j.bcp.2021.114899
Cui, H, et al. "Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy." Biochemical pharmacology vol. 197 (2021): 114899. doi: https://doi.org/10.1016/j.bcp.2021.114899
Cui H, Norrbacka S, Myöhänen TT. Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy. Biochem Pharmacol. 2021 Dec 28;197:114899. doi: 10.1016/j.bcp.2021.114899. Epub 2021 Dec 28. PMID: 34968496.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 37 entries